Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Trans-activation response element RNA (TAR RNA) is a stem-loop structure present at the 5′ ends of HIV-1 transcripts. It is central for HIV-1 transcriptional activation; binding of the viral Tat protein to TAR recruits host transcriptional machinery (notably P-TEFb, a complex of Cyclin T1 and CDK9), resulting in enhanced elongation of viral RNA by RNA polymerase II[4][2][3][5][9]. TAR RNA functions in multiple stages of the HIV life cycle: reverse transcription, transcription, genome dimerization, packaging, and modulation of innate immune responses via inhibition of PKR[2]. It also acts as a precursor to viral microRNAs that protect infected cells from apoptosis[4]. Inhibiting the Tat-TAR interaction is a major focus in HIV drug development, but no clinical drugs specifically target TAR directly[2][4]. TAR is dynamic, with both the upper stem (major Tat-binding site) and lower stem (PKR interaction) required for optimal viral replication[2]. Its function is structurally dependent: loss or mutation of critical bulges/loops impairs Tat binding and viral transcription[1][6][5]. The TAR element also serves as an enhancer for transcriptional processivity and acts as a switch for viral gene expression[7].
Tat inhibitors prevent Tat-TAR binding, disrupting HIV transcriptional elongation. PKR activators could overcome TAR's suppression of innate immunity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trans-activation response element RNA (TAR RNA).